Trial 4: Clinical Trial with Advair HFA 230 mcg/21 mcg A active-controlled, 12-week, non-US trial compared Advair HFA 230 mcg/21 mcg with fluticasone propionate CFC inhalation aerosol 220 mcg ...
GSK can breathe easy as new CEO Emma Walmsley takes over, following the FDA rejection of Mylan’s generic version of big-selling respiratory drug Advair. The US patent on Advair (fluticasone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback